113 related articles for article (PubMed ID: 20634070)
41. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
42. A ¹⁸F-labeled fluorobutyl-substituted spirocyclic piperidine derivative as a selective radioligand for PET Imaging of sigma₁ receptors.
Maisonial A; Grosse Maestrup E; Fischer S; Hiller A; Scheunemann M; Wiese C; Schepmann D; Steinbach J; Deuther-Conrad W; Wünsch B; Brust P
ChemMedChem; 2011 Aug; 6(8):1401-10. PubMed ID: 21618432
[TBL] [Abstract][Full Text] [Related]
43. Fully automated
Nagachinta S; Novelli P; Joyard Y; Maindron N; Riss P; Dammicco S
Sci Rep; 2022 Nov; 12(1):18655. PubMed ID: 36333403
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and Evaluation of (18)F-labeled Pyridaben Analogues for Myocardial Perfusion Imaging in Mice, Rats and Chinese mini-swine.
Mou T; Zhao Z; You L; Li Y; Wang Q; Fang W; Lu J; Peng C; Zhang X
Sci Rep; 2016 Sep; 6():33450. PubMed ID: 27646847
[TBL] [Abstract][Full Text] [Related]
45. (18)F Labeled benzimidazole derivatives as potential radiotracer for positron emission tomography (PET) tumor imaging.
Zhang S; Wang X; He Y; Ding R; Liu H; Xu J; Feng M; Li G; Wang M; Peng C; Qi C
Bioorg Med Chem; 2010 Apr; 18(7):2394-401. PubMed ID: 20303769
[TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
[TBL] [Abstract][Full Text] [Related]
48. Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[(18)F]fluorobenzoate and application to (18)F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography.
Johnström P; Clark JC; Pickard JD; Davenport AP
Nucl Med Biol; 2008 Aug; 35(6):725-31. PubMed ID: 18678359
[TBL] [Abstract][Full Text] [Related]
49. Alginate/galactosylated chitosan/heparin scaffold as a new synthetic extracellular matrix for hepatocytes.
Seo SJ; Choi YJ; Akaike T; Higuchi A; Cho CS
Tissue Eng; 2006 Jan; 12(1):33-44. PubMed ID: 16499440
[TBL] [Abstract][Full Text] [Related]
50. Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer:
Kuroda Y; Oda T; Shimomura O; Louphrasitthiphol P; Mathis BJ; Tateno H; Hatano K
Cancer Sci; 2023 Aug; 114(8):3364-3373. PubMed ID: 37203465
[TBL] [Abstract][Full Text] [Related]
51. An Improved Synthesis of N-(4-[
Khanapur S; Yong FF; Hartimath SV; Jiang L; Ramasamy B; Cheng P; Narayanaswamy P; Goggi JL; Robins EG
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808813
[TBL] [Abstract][Full Text] [Related]
52. Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[
Zhou Z; McDougald D; Devoogdt N; Zalutsky MR; Vaidyanathan G
Mol Pharm; 2019 Jan; 16(1):214-226. PubMed ID: 30427188
[TBL] [Abstract][Full Text] [Related]
53. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.
de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F
Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096
[TBL] [Abstract][Full Text] [Related]
54. Dopamine D(4) receptor antagonist 3-(4-[(18)F]fluorobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one([(18)F]FMTP): radiosynthesis and in vivo characterization in rats.
Hai-Bin T; Duan-Zhi Y; Lan Z; Li-Hua W; Chun-Fu Z; Ming-Wei W; Chun-Ying W; Gu-Cai L; Yong-Xian W
Appl Radiat Isot; 2005 Sep; 63(3):333-42. PubMed ID: 15972259
[TBL] [Abstract][Full Text] [Related]
55. Radiolabeling and in vitro and in vivo characterization of [18F]FB-[R(8,15,21), L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors.
Cheng D; Yin D; Li G; Wang M; Li S; Zheng M; Cai H; Wang Y
Chem Biol Drug Des; 2006 Dec; 68(6):319-25. PubMed ID: 17177894
[TBL] [Abstract][Full Text] [Related]
56. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of
Arimitsu K; Yagi Y; Koshino K; Nishito Y; Higuchi T; Yasui H; Kimura H
Bioorg Med Chem Lett; 2020 Sep; 30(17):127400. PubMed ID: 32738964
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and preliminary evaluation of a
Wu X; You L; Zhang D; Gao M; Li Z; Xu D; Zhang P; Huang L; Zhuang R; Wu H; Zhang X
Chem Biol Drug Des; 2017 Apr; 89(4):559-565. PubMed ID: 27696769
[TBL] [Abstract][Full Text] [Related]
59. (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells.
Richter S; Bouvet V; Wuest M; Bergmann R; Steinbach J; Pietzsch J; Neundorf I; Wuest F
Nucl Med Biol; 2012 Nov; 39(8):1202-12. PubMed ID: 22784382
[TBL] [Abstract][Full Text] [Related]
60. Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET.
Mori T; Sun LQ; Kobayashi M; Kiyono Y; Okazawa H; Furukawa T; Kawashima H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2009 Feb; 36(2):155-62. PubMed ID: 19217527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
